New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 16, 2012
07:07 EDTARWRArrowHead Research receives allowance for patent for DPC
Arrowhead Research announced that it received a Notice of Allowance from the U.S. Patent and Trademark Office, or USPTO, for patent application U.S. 13/032,029 entitled, " Compositions for Targeted Delivery of siRNA." The patent broadly covers compositions, methods, and uses for a new formulation of Arrowhead's Dynamic Polyconjugate, or DPC, siRNA delivery platform, where attachment of siRNA and delivery vehicle is not required to produce high-level, efficient knockdown of target genes. The new IP expands the DPC platform and is used in Arrowhead's ARC-520 candidate in development for chronic hepatitis B virus infection.
News For ARWR From The Last 14 Days
Check below for free stories on ARWR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 14, 2014
14:42 EDTARWRAlnylam slips after Novartis reportedly cuts back RNAi development
Subscribe for More Information
April 9, 2014
16:39 EDTARWRPoint72 boosts stake in Arrowhead Research to 7.1% from 5.2%
Subscribe for More Information
April 8, 2014
16:39 EDTARWRIntegrated Core Strategies reports 4.9% passive stake in Arrowhead Research
April 2, 2014
15:03 EDTARWRArrowhead Research management to meet with Piper Jaffray
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use